Thomas R. Gadek
51 works · 6,455 citations · h-index 21
Top works
- Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
- Cyclic RGD peptide analogs as antiplatelet antithrombotics
- From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold
- A surprising observation about Mitsunobu reactions in solid phase synthesis
- Generation of an LFA-1 Antagonist by the Transfer of the ICAM-1 Immunoregulatory Epitope to a Small Molecule
- Small molecule antagonists of proteins
- Chapter 9. Glycoprotein IIb IIIa Antagonists
- Structural studies of potent constrained RGD peptides
- Modification of CD4 Immunoadhesin with Monomethoxypoly(Ethylene Glycol) Aldehyde via Reductive Alkylation
- From Peptide to Non-Peptide. 1. The Elucidation of a Bioactive Conformation of the Arginine-Glycine-Aspartic Acid Recognition Sequence
- Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye
- Carbanion mechanism in the alkylation of certain tosylhydrazones. 9,9-Disubstituted fluorenes from fluorenone tosylhydrazone
- RGD Mimetics containing a central hydantoin scaffold: αVβ3 vs αIIbβ3 selectivity requirements
- Cobalt Mediated [2 + 2 + 2]‐Cycloadditions: Stereospecific Intramolecular Reactions of Enediynes to Tricyclic Dienes Bearing Angular Methyl Groups
- Safety and Pharmacokinetics of a Novel Lymphocyte Function-associated Antigen-1 Antagonist Ophthalmic Solution (SAR 1118) in Healthy Adults
- Trimethylsilyl triflate mediated introduction of phospholipid head groups
- Two new procedures for the introduction of benzyl-type protecting groups for thiols
- Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease
- Corneal Inflammation Is Inhibited by the LFA-1 Antagonist, Lifitegrast (SAR 1118)
- Competition between intercellular adhesion molecule‐1 and a small‐molecule antagonist for a common binding site on the αl subunit of lymphocyte function‐associated antigen‐1